The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases
Chen, Zhongbo; Reynolds, Regina H; Pardiñas, Antonio F; Gagliano Taliun, Sarah A; van Rheenen, Wouter; Lin, Kuang; Shatunov, Aleksey; Gustavsson, Emil K; Fogh, Isabella; Jones, Ashley R; Robberecht, Wim; Corcia, Philippe; Chiò, Adriano; Shaw, Pamela J; Morrison, Karen E; Veldink, Jan H; van den Berg, Leonard H; Shaw, Christopher E; Powell, John F; Silani, Vincenzo; Hardy, John A; Houlden, Henry; Owen, Michael J; Turner, Martin R; Ryten, Mina; Al-Chalabi, Ammar
(2023) Neurobiology of Disease, volume 180
(Article)
Abstract
Humans are thought to be more susceptible to neurodegeneration than equivalently-aged primates. It is not known whether this vulnerability is specific to anatomically-modern humans or shared with other hominids. The contribution of introgressed Neanderthal DNA to neurodegenerative disorders remains uncertain. It is also unclear how common variants associated with neurodegenerative
... read more
disease risk are maintained by natural selection in the population despite their deleterious effects. In this study, we aimed to quantify the genome-wide contribution of Neanderthal introgression and positive selection to the heritability of complex neurodegenerative disorders to address these questions. We used stratified-linkage disequilibrium score regression to investigate the relationship between five SNP-based signatures of natural selection, reflecting different timepoints of evolution, and genome-wide associated variants of the three most prevalent neurodegenerative disorders: Alzheimer's disease, amyotrophic lateral sclerosis and Parkinson's disease. We found no evidence for enrichment of positively-selected SNPs in the heritability of Alzheimer's disease, amyotrophic lateral sclerosis and Parkinson's disease, suggesting that common deleterious disease variants are unlikely to be maintained by positive selection. There was no enrichment of Neanderthal introgression in the SNP-heritability of these disorders, suggesting that Neanderthal admixture is unlikely to have contributed to disease risk. These findings provide insight into the origins of neurodegenerative disorders within the evolution of Homo sapiens and addresses a long-standing debate, showing that Neanderthal admixture is unlikely to have contributed to common genetic risk of neurodegeneration in anatomically-modern humans.
show less
Download/Full Text
Keywords: Alzheimer's disease, Amyotrophic lateral sclerosis, Evolution, Genetics, Natural selection, Neanderthal, Neurodegenerative diseases, Parkinson's disease, Neurology, Journal Article
ISSN: 0969-9961
Publisher: Academic Press Inc.
Note: Funding Information: Z.C. is funded by a Leonard Wolfson Foundation clinical research fellowship in neurodegeneration. I.F. receives salary support from the National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London. I.F. is also funded by the Motor Neurone Disease Association (Grant number 905-793, 6058). W.R. is supported through the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders, the Laevers Fund for ALS Research, the ALS Liga België, the fund ‘Een Hart voor ALS’ and the fund ‘Opening the Future’. MRT is supported by the Motor Neurone Disease Association. AAC is an NIHR Senior Investigator (NIHR202421). This is an EU Joint Programme - Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organisations under the aegis of JPND - www.jpnd.eu (United Kingdom, Medical Research Council (MR/L501529/1; MR/R024804/1) and Economic and Social Research Council (ES/L008238/1)) and through the Motor Neurone Disease Association, My Name’5 Doddie Foundation, and Alan Davidson Foundation. This study represents independent research part funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College Londona. The work leading up to this publication was funded by the European Community's Health Seventh Framework Programme (FP7/2007–2013; grant agreement number 259867 and 340429). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. MR is supported through the award of a Tenure Track Medical Research Council (MRC) Clinician Scientist Fellowship (MR/N008324/1). Funding Information: Z.C. is funded by a Leonard Wolfson Foundation clinical research fellowship in neurodegeneration. I.F. receives salary support from the National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London . I.F. is also funded by the Motor Neurone Disease Association (Grant number 905-793, 6058 ). W.R. is supported through the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders, the Laevers Fund for ALS Research , the ALS Liga België , the fund ‘Een Hart voor ALS’ and the fund ‘Opening the Future’ . MRT is supported by the Motor Neurone Disease Association . AAC is an NIHR Senior Investigator ( NIHR202421 ). This is an EU Joint Programme - Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organisations under the aegis of JPND - www.jpnd.eu (United Kingdom, Medical Research Council ( MR/L501529/1 ; MR/R024804/1 ) and Economic and Social Research Council ( ES/L008238/1 )) and through the Motor Neurone Disease Association , My Name’5 Doddie Foundation , and Alan Davidson Foundation . This study represents independent research part funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College Londona . The work leading up to this publication was funded by the European Community's Health Seventh Framework Programme (FP7/2007–2013; grant agreement number 259867 and 340429 ). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. MR is supported through the award of a Tenure Track Medical Research Council (MRC) Clinician Scientist Fellowship (MR/N008324/1). Publisher Copyright: © 2023
(Peer reviewed)